Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:09 PM
Ignite Modification Date:
2025-12-24 @ 11:09 PM
NCT ID:
NCT04733469
Eligibility Criteria:
Inclusion Criteria:
1. Adult, age 18 or older
2. Meets criteria for 2a or 2b. 2a) The patient's doctor believes they may be appropriate for palliative cancer care OR 2b) The patient has a new diagnosis, recurrence, or progression of cancer in the past 90 days AND any of the following:
* Advanced cancer, such as:
* Lung Cancer: Stage IIIB or IV non-small cell, or extensive stage small cell
* Breast Cancer: Stage IV
* Gastrointestinal (GI) Cancers: Unresectable stage III or stage IV
* Genitourinary (GU) Cancers: Stage IV
* Melanoma: Stage IV
* Hematologic Malignancies
* Leukemia (e.g., acute myeloid leukemia \[AML\], acute lymphoblastic leukemia \[ALL\], chronic myeloid leukemia (CML), chronic lymphocytic leukemia \[CLL\]): advanced stage, treatment refractory, poor prognosis cell type or chromosomal abnormalities, older age
* Lymphoma: Stage IV or treatment refractory Hodgkin's disease or non-Hodgkin's lymphoma Multiple Myeloma: elevated β2-microglobulin, albumin \<3.5, PCLI \>1%, CRP \>6µg/mL, elevated LDH, plasmablastic morphology, or abnormal chromosome 13
* Advanced heart, lung, renal (kidney), or liver disease
* Two or more severe symptoms (≥7 on 0-10 scale): pain, tiredness, drowsiness, nausea, bad appetite, shortness of breath, depression, or anxiety
3. Patient can understand spoken or written English
4. Patient receives care in southeast Louisiana
Exclusion Criteria:
* Known history of receiving specialty palliative care or hospice
* Significant psychiatric or other co-morbid disease that would prohibit informed consent or participation in the study
* Unlikely to complete any follow-up surveys
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04733469
Study Brief:
Protocol Section:
NCT04733469